Table 2 Laboratory findings immediately before the administration of intracranial pressure-reducing agents

WBC, 10⁹/L

12.5 (10.2–14.7)

10.1 (9.1–12.2)

1.4 (8.1–13.4)

Hb, g/dL

9.5 (8.6–11.3)

8.2 (7.8–10.4)

9.4 (8.9–10.0)

CRP, mg/dL

8.1 (3.8–14.5)

5.7 (0.7–9.5)

5.1 (2.7–9.5)

Alb, g/dL

2.3 (2.1–2.7)

2.6 (2.3–3.2)

3.0 (2.5–3.4)

BUN, mg/dL

10 (9–13)

12 (8–19)

14 (10–16)

Creatinine, mg/dL

0.67 (0.49–0.87)

0.51 (0.43–1.11)

0.61 (0.50–0.97)

T-Bil, mg/dL

0.75 (0.47–1.08)

0.95 (0.56–1.68)

1.01 (0.67–1.24)

AST, U/L

28 (18–48)

26 (21–37)

29 (23–83)

ALT, U/L

18 (13–37)

19 (14–43)

20 (15–57)

LDH, U/L

249 (182–328)

231 (166–269)

216 (182–246)

P, mg/dL

2.6 (2.0–2.8)

2.8 (1.9–3.3)

2.7 (2.2–3.1)

ChE, U/L

205 (155–234)

139 (115–185)

195 (79–232)

SOFA

3 (2–5)

6 (3–7)

3 (3–4)

Mechanical ventilation

46.1%

76.9%

71.4%